Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Immune system changes may contribute to female pattern hair loss.

The mouse model showed defects in adult stem cell maintenance related to Hutchinson-Gilford progeria syndrome.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Platelet-rich plasma may help hair follicle cells grow by affecting certain genes and pathways.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

TGF-β2 helps yak hair follicles enter the regression phase, while HSP70 tries to prevent it.

IL-10 may worsen alopecia areata instead of helping it.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Alopecia areata involves unique activation of certain immune cells.

ILC1-like cells can independently cause alopecia areata.

Higher IL-21 levels may help predict alopecia areata activity.

PRP may help reduce brain inflammation and protect brain cells.

Identical twins had different symptoms because one had more cells with an extra chromosome fragment in different tissues.

Integrin alpha-6 and p63 proteins may play a role in hair loss and are important for hair growth and maintenance.

These gene variations are not linked to alopecia areata in Egyptians.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.